Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-23-037389
Filing Date
2023-08-02
Accepted
2023-08-02 18:04:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3598
  Complete submission text file 0000950170-23-037389.txt   5145
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Subject) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35005 | Film No.: 231137348
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ASSEMBLY BIOSCIENCES, INC. 331 OYSTER POINT BLVD, FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Okazaki Jason A (Reporting) CIK: 0001807214 (see all company filings)

Type: 144